Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study

MLA

Yong-Xian Shao, et al. “Clinical Spectrum, over 12-Year Follow-up and Experience of SGLT2 Inhibitors Treatment on Patients with Glycogen Storage Disease Type Ib: A Single-Center Retrospective Study.” Orphanet Journal of Rare Diseases, vol. 19, no. 1, Apr. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13023-024-03137-6.

APA

Yong-Xian Shao, Cui-Li Liang, Ya-Ying Su, Yun-Ting Lin, Zhi-Kun Lu, Rui-Zhu Lin, Zhi-Zi Zhou, Chun-Hua Zeng, Chun-Yan Tao, Zong-Cai Liu, Wen Zhang, & Li Liu. (2024). Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study. Orphanet Journal of Rare Diseases, 19(1), 1–11. https://doi.org/10.1186/s13023-024-03137-6

Chicago

Yong-Xian Shao, Cui-Li Liang, Ya-Ying Su, Yun-Ting Lin, Zhi-Kun Lu, Rui-Zhu Lin, Zhi-Zi Zhou, et al. 2024. “Clinical Spectrum, over 12-Year Follow-up and Experience of SGLT2 Inhibitors Treatment on Patients with Glycogen Storage Disease Type Ib: A Single-Center Retrospective Study.” Orphanet Journal of Rare Diseases 19 (1): 1–11. doi:10.1186/s13023-024-03137-6.